Data search
Results for MligTC455_10896
| Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
|---|---|---|---|---|---|---|
| MligTC455_10896 | 19 | 0.39 | Mlig455_015889, Mlig455_057073 | Neo: - Age: - |
Mlig455_015889 {REF} {Length: 1435} {NoTransDecoderORF} {RNA1509_51255} {RNA1310_60503} {RNA815_39433} Mlig455_057073 {REF} {Length: 1456} {Pfam: Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=27.0]} {Smed: dd_Smed_v6_129_2_1, dd_Smed_v6_129_2_1, [Score=194, Expect=8e-55]} {RNA1509_47004} {RNA1310_23647} {RNA815_13375.1} |
Cumulative graph for MligTC455_10896
Region-enriched expression
| Region | logFC | logCPM | Pvalue | FDR | Specificity |
|---|---|---|---|---|---|
| RegionR1 | - | - | - | - | |
| RegionR2 | - | - | - | - | |
| RegionR3 | - | - | - | - | |
| RegionR4 | - | - | - | - | |
| RegionR5 | - | - | - | - | |
| RegionR6 | - | - | - | - | |
| RegionR7 | - | - | - | - | |
| RegionR8 | - | - | - | - |
Regeneration-enriched expression
| Region | logFC | logCPM | PValue | FDR | Specificity |
|---|---|---|---|---|---|
| RegenerationR1 | - | - | - | - | |
| RegenerationR2 | - | - | - | - | |
| RegenerationR3 | - | - | - | - | |
| RegenerationR4 | - | - | - | - | |
| RegenerationR5 | - | - | - | - | |
| RegenerationR6 | - | - | - | - | |
| RegenerationBL | - | - | - | - | |
| RegenerationTP | - | - | - | - |
Genes with expression patterns similar to MligTC455_10896
| Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | MligTC455_10896 | 19 | 0.39 | Mlig455_015889, Mlig455_057073 | Neo: - Age: - |
1 | - | - | 1.000 | - | - | - | Mlig455_015889 {REF} {Length: 1435} {NoTransDecoderORF} {RNA1509_51255} {RNA1310_60503} {RNA815_39433} Mlig455_057073 {REF} {Length: 1456} {Pfam: Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=27.0]} {Smed: dd_Smed_v6_129_2_1, dd_Smed_v6_129_2_1, [Score=194, Expect=8e-55]} {RNA1509_47004} {RNA1310_23647} {RNA815_13375.1} |
|
| 2. | MligTC455_47373 | 30 | 0.63 | Mlig455_050214, Mlig455_050224 | Neo: - Age: - |
1 | - | - | 1.000 | - | - | - | Mlig455_050214 {REF} {Length: 754} {RNA1310_130371} Mlig455_050224 {REF} {Length: 769} {RNA1310_130371} |
|
| 3. | MligTC455_33337 | 12 | 0.25 | Mlig455_064063 | Neo: - Age: Down-Up-Down |
TRPM5 | 0.996 | - | - | 0.996 | - | - | - | Mlig455_064063 {REF} {Length: 6911} {Pfam: Ion transport protein [PF00520.33, score=61.4]} {Human: ENSG00000070985, TRPM5, transient receptor potential cation channel subfamily M member 5, [Score=247, Expect=5e-66]; ENSG00000083067, TRPM3, transient receptor potential cation channel subfamily M member 3, [Score=247, Expect=2e-65]; ENSG00000134160, TRPM1, transient receptor potential cation channel subfamily M member 1, [Score=240, Expect=2e-63]; ENSG00000274965, TRPM1, transient receptor potential cation channel subfamily M member 1, [Score=240, Expect=2e-63]} {Mouse: ENSMUSG00000052387, Trpm3, transient receptor potential cation channel, subfamily M, member 3, [Score=252, Expect=3e-67]} {Dmel: FBgn0265194, Trpm, Transient receptor potential cation channel, subfamily M, [Score=229, Expect=3e-60]} {Celegans: WBGene00001796, gtl-2, Gon-Two Like (TRP subfamily), [Score=167, Expect=2e-41]} {Smed: dd_Smed_v6_17981_0_2, dd_Smed_v6_17981_0_2, [Score=578, Expect=0.0]} {RNA1509_14127} {RNA1310_477.1} {RNA815_16162} |
| 4. | MligTC455_06627 | 26 | 0.54 | Mlig455_068129 | Neo: - Age: - |
0.984 | - | - | 0.984 | - | - | - | Mlig455_068129 {REF} {Length: 497} {NoTransDecoderORF} {RNA1310_82453} | |
| 5. | MligTC455_16175 | 64 | 1.34 | Mlig455_047192 | Neo: - Age: - |
GCM1 | 0.984 | - | - | 0.984 | - | - | - | Mlig455_047192 {REF} {Length: 2352} {Pfam: GCM motif protein [PF03615.17, score=223.0]} {Human: ENSG00000137270, GCM1, glial cells missing homolog 1, [RH, Score=196, Expect=4e-57]; ENSG00000124827, GCM2, glial cells missing homolog 2, [RH, Score=191, Expect=2e-54]} {Mouse: ENSMUSG00000023333, Gcm1, glial cells missing homolog 1, [RH, Score=192, Expect=1e-55]; ENSMUSG00000021362, Gcm2, glial cells missing homolog 2, [RH, Score=188, Expect=1e-53]} {Dmel: FBgn0014179, gcm, glial cells missing, [RH, Score=229, Expect=3e-69]} {Smed: dd_Smed_v6_15107_0_1, dd_Smed_v6_15107_0_1, [RH, Score=186, Expect=3e-54]} {RNA1509_58813} {RNA1310_66943} {RNA815_43872} |
| 6. | MligTC455_49219 | 16 | 0.32 | Mlig455_039874 | Neo: - Age: Up-Down-Down |
FUT3 | 0.976 | - | - | 0.976 | - | - | - | Mlig455_039874 {REF} {Length: 3026} {Pfam: Glycosyltransferase family 10 (fucosyltransferase) C-term [PF00852.21, score=165.6]; Fucosyltransferase, N-terminal [PF17039.7, score=47.8]} {Human: ENSG00000171124, FUT3, fucosyltransferase 3 (Lewis blood group), [Score=134, Expect=1e-34]; ENSG00000156413, FUT6, fucosyltransferase 6, [Score=130, Expect=2e-33]} {Mouse: ENSMUSG00000055373, Fut9, fucosyltransferase 9, [Score=120, Expect=6e-30]} {Dmel: FBgn0036485, FucTA, [Score=124, Expect=8e-31]} {Celegans: WBGene00020222, fut-6, Alpha-(1,3)-fucosyltransferase fut-6, [RH, Score=114, Expect=8e-28]} {Smed: dd_Smed_v6_8368_0_1, dd_Smed_v6_8368_0_1, [Score=135, Expect=5e-35]} {RNA1310_77356} |
| 7. | MligTC455_06716 | 327 | 6.81 | Mlig455_036045, Mlig455_036046, Mlig455_036144, Mlig455_036145, Mlig455_036170 | Neo: - Age: - |
SSPO | 0.975 | - | - | 0.975 | - | - | - | Mlig455_036045 {REF} {Length: 10776} {Pfam: Domain of unknown function (DUF5047) [PF16466.7, score=44.7]; Polysaccharide lyase family 8, C-terminal beta-sandwich domain [PF02884.19, score=42.6]} {RNA1310_32644.1} {RNA815_19867} Mlig455_036046 {REF} {Length: 10754} {Pfam: von Willebrand factor type D domain [PF00094.27, score=103.0]; Low-density lipoprotein receptor domain class A [PF00057.20, score=72.2]; C8 domain [PF08742.13, score=55.7]; Polysaccharide lyase family 8, C-terminal beta-sandwich domain [PF02884.19, score=41.8]; Trypsin Inhibitor like cysteine rich domain [PF01826.19, score=40.4]; Domain of unknown function (DUF5047) [PF16466.7, score=33.5]} {Human: ENSG00000197558, SSPO, SCO-spondin, [Score=369, Expect=4e-101]} {Mouse: ENSMUSG00000029797, Sspo, SCO-spondin, [Score=315, Expect=4e-85]} {Dmel: FBgn0029167, Hml, Hemolectin, [Score=221, Expect=6e-57]} {Celegans: WBGene00019756, M03E7.4, [RH, Score=117, Expect=2e-26]} {Smed: dd_Smed_v6_9342_0_1, dd_Smed_v6_9342_0_1, [Score=749, Expect=0.0]} {RNA1509_1916} {RNA1310_32644.1} {RNA815_19867} Mlig455_036144 {REF} {Length: 12316} {Pfam: Spondin-like TSP1 domain [PF19028.2, score=86.3]; Domain of unknown function (DUF5047) [PF16466.7, score=42.4]; Polysaccharide lyase family 8, C-terminal beta-sandwich domain [PF02884.19, score=40.6]; Trypsin Inhibitor like cysteine rich domain [PF01826.19, score=39.8]; Thrombospondin type 1 domain [PF00090.21, score=39.2]} {Human: ENSG00000197558, SSPO, SCO-spondin, [Score=125, Expect=2e-27]} {Mouse: ENSMUSG00000029797, Sspo, SCO-spondin, [Score=102, Expect=2e-20]} {Celegans: WBGene00011880, T21B6.3, [Score=82.0, Expect=7e-15]} {Smed: dd_Smed_v6_628_0_1, dd_Smed_v6_628_0_1, [Score=318, Expect=1e-89]} {RNA1310_32644.1} {RNA815_19867} Mlig455_036145 {REF} {Length: 13058} {Pfam: von Willebrand factor type D domain [PF00094.27, score=206.7]; C8 domain [PF08742.13, score=93.9]; Low-density lipoprotein receptor domain class A [PF00057.20, score=65.0]; Trypsin Inhibitor like cysteine rich domain [PF01826.19, score=55.1]; Polysaccharide lyase family 8, C-terminal beta-sandwich domain [PF02884.19, score=34.6]; Domain of unknown function (DUF5047) [PF16466.7, score=31.9]} {Human: ENSG00000197558, SSPO, SCO-spondin, [RH, Score=558, Expect=2e-158]} {Mouse: ENSMUSG00000029797, Sspo, SCO-spondin, [Score=472, Expect=2e-132]} {Dmel: FBgn0029167, Hml, Hemolectin, [Score=335, Expect=4e-91]} {Celegans: WBGene00020481, T13C2.6, [Score=132, Expect=4e-30]} {Smed: dd_Smed_v6_9342_0_1, dd_Smed_v6_9342_0_1, [RH, Score=1224, Expect=0.0]} {RNA1509_1916} {RNA1310_608} {RNA815_152.1} Mlig455_036170 {REF} {Length: 29933} {Pfam: von Willebrand factor type D domain [PF00094.27, score=202.4]; C8 domain [PF08742.13, score=83.2]; Spondin-like TSP1 domain [PF19028.2, score=70.6]; Polysaccharide lyase family 8, C-terminal beta-sandwich domain [PF02884.19, score=69.2]; Domain of unknown function (DUF5047) [PF16466.7, score=63.6]; Trypsin Inhibitor like cysteine rich domain [PF01826.19, score=63.2]; Low-density lipoprotein receptor domain class A [PF00057.20, score=61.3]; Thrombospondin type 1 domain [PF00090.21, score=36.1]} {Human: ENSG00000197558, SSPO, SCO-spondin, [Score=533, Expect=5e-150]} {Mouse: ENSMUSG00000029797, Sspo, SCO-spondin, [Score=466, Expect=5e-130]} {Dmel: FBgn0029167, Hml, Hemolectin, [Score=327, Expect=4e-88]} {Celegans: WBGene00019756, M03E7.4, [Score=112, Expect=3e-24]} {Smed: dd_Smed_v6_9342_0_1, dd_Smed_v6_9342_0_1, [RH, Score=1177, Expect=0.0]} {RNA1509_1916} {RNA1310_608} {RNA815_152.1} |
| 8. | MligTC455_19759 | 18 | 0.39 | Mlig455_002694, Mlig455_002710 | Neo: - Age: - |
0.975 | - | - | 0.975 | - | - | - | Mlig455_002694 {REF} {Length: 1408} {RNA1310_38437} {RNA815_40458} Mlig455_002710 {REF} {Length: 1745} {RNA1310_38437} {RNA815_40458} |
|
| 9. | MligTC455_15399 | 36 | 0.74 | Mlig455_055560 | Neo: - Age: - |
0.969 | - | - | 0.969 | - | - | - | Mlig455_055560 {REF} {Length: 1702} {RNA1509_43538} {RNA1310_53010} {RNA815_29980} | |
| 10. | MligTC455_37809 | 28 | 0.58 | Mlig455_053421 | Neo: - Age: - |
0.963 | - | - | 0.963 | - | - | - | Mlig455_053421 {REF} {Length: 1283} {RNA1509_44223} {RNA1310_90388} {RNA815_47782} | |
| 11. | MligTC455_17340 | 117 | 2.43 | Mlig455_056518 | Neo: - Age: - |
CHRNA3 | 0.962 | - | - | 0.962 | - | - | - | Mlig455_056518 {REF} {Length: 2896} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=68.3]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=63.9, Expect=1e-11]} {Mouse: ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=59.7, Expect=2e-10]; ENSMUSG00000035594, Chrna5, cholinergic receptor, nicotinic, alpha polypeptide 5, [Score=59.3, Expect=3e-10]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=57.0, Expect=2e-09]} {Dmel: FBgn0086778, nAChRalpha7, nicotinic Acetylcholine Receptor alpha7, [Score=63.5, Expect=7e-12]} {Celegans: WBGene00001133, eat-2, Neuronal acetylcholine receptor subunit eat-2, [Score=56.2, Expect=2e-09]} {Smed: dd_Smed_v6_8058_0_1, dd_Smed_v6_8058_0_1, [Score=56.2, Expect=1e-09]} {RNA1509_7752} {RNA1310_57458} {RNA815_42787} |
| 12. | MligTC455_25805 | 30 | 0.63 | Mlig455_044209 | Neo: - Age: - |
0.959 | - | - | 0.959 | - | - | - | Mlig455_044209 {REF} {Length: 5863} {RNA1509_55535} {RNA1310_78838.1} {RNA815_24119.1} | |
| 13. | MligTC455_09000 | 8 | 0.17 | Mlig455_035922 | Neo: - Age: - |
0.955 | - | - | 0.955 | - | - | - | Mlig455_035922 {REF} {Length: 1657} {RNA1310_49348} {RNA815_52779} | |
| 14. | MligTC455_18515 | 24 | 0.5 | Mlig455_008323 | Neo: - Age: - |
FARP2 | 0.955 | - | - | 0.955 | - | - | - | Mlig455_008323 {REF} {Length: 4459} {TRANSSPLICED} {Pfam: FERM C-terminal PH-like domain [PF09380.12, score=79.0]; FERM N-terminal domain [PF09379.12, score=61.5]; FERM central domain [PF00373.20, score=47.5]; FERM adjacent (FA) [PF08736.13, score=34.0]} {Human: ENSG00000006607, FARP2, FERM, ARH/RhoGEF and pleckstrin domain protein 2, [RH, Score=326, Expect=5e-99]; ENSG00000152767, FARP1, FERM, ARH/RhoGEF and pleckstrin domain protein 1, [RH, Score=317, Expect=3e-94]} {Mouse: ENSMUSG00000034066, Farp2, FERM, RhoGEF and pleckstrin domain protein 2, [RH, Score=330, Expect=3e-99]} {Dmel: FBgn0265082, Cdep, Chondrocyte-derived ezrin-like domain containing protein, [Score=367, Expect=1e-117]} {Celegans: WBGene00001490, frm-3, FERM domain (Protein4.1-ezrin-radixin-moesin) family, [Score=350, Expect=4e-104]} {Smed: dd_Smed_v6_5600_0_1, dd_Smed_v6_5600_0_1, [Score=433, Expect=5e-131]} {RNA1509_50345} {RNA1310_4844, RNA1509_50345} {RNA1509_50345, RNA815_16713} |
| 15. | MligTC455_37489 | 38 | 0.8 | Mlig455_063956 | Neo: - Age: - |
0.955 | - | - | 0.955 | - | - | - | Mlig455_063956 {REF} {Length: 4044} {RNA1310_69299} {RNA815_47623} | |
| 16. | MligTC455_32021 | 34 | 0.72 | Mlig455_007086 | Neo: - Age: - |
0.952 | - | - | 0.952 | - | - | - | Mlig455_007086 {REF} {Length: 3012} {Pfam: Alpha-L-arabinofuranosidase B (ABFB) domain [PF05270.15, score=49.2]} {RNA1509_22651} {RNA1310_622.1} {RNA815_2514.1} | |
| 17. | MligTC455_23098 | 38 | 0.78 | Mlig455_019169 | Neo: - Age: - Region-enriched R2: 6.693/0.03013 |
NR2E3 | 0.951 | - | - | 0.951 | - | - | - | Mlig455_019169 {REF} {Length: 2731} {Pfam: Zinc finger, C4 type (two domains) [PF00105.20, score=97.7]; Ligand-binding domain of nuclear hormone receptor [PF00104.32, score=85.2]} {Human: ENSG00000278570, NR2E3, nuclear receptor subfamily 2 group E member 3, [RH, Score=220, Expect=3e-64]} {Mouse: ENSMUSG00000032292, Nr2e3, nuclear receptor subfamily 2, group E, member 3, [RH, Score=216, Expect=8e-63]} {Dmel: FBgn0034012, Hr51, Hormone receptor 51, [RH, Score=189, Expect=2e-51]} {Celegans: WBGene00001400, fax-1, Nuclear hormone receptor FAX-1, [RH, Score=179, Expect=1e-49]} {Smed: dd_Smed_v6_24412_0_1, dd_Smed_v6_24412_0_1, [RH, Score=196, Expect=3e-54]} {RNA1310_101745} |